期刊文献+

高龄非瓣膜病心房颤动患者抗栓治疗调查 被引量:2

Analysis of antithrombotic therapy in senile patients with non-valvular atrial fibrillation
暂未订购
导出
摘要 目的调查华东医院心内科≥80岁非瓣膜病心房颤动患者临床特征及抗血栓药物治疗的情况,了解用药现状。方法调查≥80岁非瓣膜病房颤患者84例,对其危险因素等临床特征及抗血栓药物使用情况进行分析。结果非瓣膜性房颤的病因以冠心病、高血压病、肺源性心脏病、甲状腺功能亢进、孤立性房颤及扩张型心肌病为主。84例患者中,绝大多数合并多种危险因素,其中应用华法林者只有6例(7.1%),应用阿司匹林者56例(66.7%),其他抗血小板药物7例(8.3%),未应用抗血栓药物15例(17.9%)。结论高龄非瓣膜病房颤患者华法林应用率低,抗血小板药使用率高。 Objective To analyze antithrombotic therapy in patients with atrial fibrillation who were older than 80 years. Methods Antithrombotic medicines and cardiac embolic risk factors were registered and analyzed in 84 patients with non-valvular atrial fibrillation who were older than 80 years. Results Most patients had multiple embolic risk factors. Of the 84 patients, 6 were prescribed with warfarin, 56 were given aspirin, 7 were administered with other antiplatelet medicines, and 15 did not use any antithrombotic medicines. Conclusions Warfarin was prescribed only in a small proportion of senile patients with non-valvular atrial fibrillation, and aspirin was used more frequently.
出处 《老年医学与保健》 CAS 2009年第2期109-111,共3页 Geriatrics & Health Care
关键词 心房颤动 血栓溶解疗法 华法林 阿司匹林 Atrial fibrillation Antithrombotic therapy Warfarin Aspirin
  • 相关文献

参考文献11

  • 1Go AS, Hylek EM, Chang Y, et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study. JAMA, 2001, 285: 2370-2375.
  • 2ACC/AHA/ESC 2006 Guidelines for the Management of Patients with Atrial Fibrillation- Executive Summary. A Report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With AtrialFibrillation). Circulation, 2006, 114: 700-752.
  • 3Copper NS, Sutton AJ, Lu K, et al. Mixed comparison of stroke prevention treatments in individuals with nonrheumatic atrial fibrillation. Arch Intern Med, 2006, 12: 1269-1275.
  • 4Van Walraven C, Hart RG, Singer DE, et al. Oral anticoagulantsvs. aspirin in nonvalvular atrial fibrillation-an individual patient meta-analysis. JAMA, 2002, 288: 2441-2448.
  • 5Waldo AL, Becker RC, Tapson VF, et al. NABOR Steering Committee. Hospitalized patients with atrial fibrillation and a high risk of stroke are not being provided with adequate anticoagulation. J Am Coil Cardiol. 2005, 46: 1729-1736.
  • 6Somerfield J, Barber PA, Anderson NE, et al. NOt all patients with atrial fibrillation-associated ischemic stroke can be started on anticoagulant thempy. Stroke, 2006, 37: 1217-1220.
  • 7戚文航.中国部分地区心房颤动住院病例回顾性调查[J].中华心血管病杂志,2003,31(12):913-916. 被引量:381
  • 8周自强,胡大一,陈捷,张仁汉,李奎宝,赵秀丽.中国心房颤动现状的流行病学研究[J].中华内科杂志,2004,43(7):491-494. 被引量:1408
  • 9抗心律失常药物治疗专题组.抗心律失常药物治疗建议[J].中华心血管病杂志,2001,29(6):323-336. 被引量:789
  • 10孙艺红,胡大一.华法林对中国人心房颤动患者抗栓的安全性和有效性研究[J].中华内科杂志,2004,43(4):258-260. 被引量:171

二级参考文献33

共引文献2734

同被引文献35

  • 1左惠娟,苏江莲,曾辉,袁宝弘,姚崇华.北京市非瓣膜心房颤动病人日常抗血栓治疗现况分析[J].中华医学杂志,2007,87(33):2328-2331. 被引量:18
  • 2Heeringa J, van der Kuip DA, Hofman A, et al. Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study[J].Eur Heart J, 2006,27 (8) : 949-953.
  • 3Wyndham CR. Atrial fibrillation: the most common arrhythmia [ J ].Tex Heart Inst J, 2000,27 ( 3 ) : 257 -267.
  • 4Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study[ J ] .Stroke, 1991,22(8) : 983-988.
  • 5Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five ran- domized controlled trials [ J]. Arch Intern Med, 1994, 154 (13) :1449-1457.
  • 6Singer DE, Albers GW, Dalen JE, et al. Antithrombotic therapy in atrial fibrillation: the Seventh ACCP Conference on Antithrombotie and Thrombolytie Therapy [ J ]. Chest, 2004,126( 3 Suppl) :429S-456S.
  • 7Levine MN, Raskob G, Beyth R J, et al. Hemorrhagic com- plications of anticoagulant treatment: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy[ J]. Chest, 2004,126(3 Suppl) :287S-310S.
  • 8刘彩玲,朱时法.华法林在慢性心房纤颤患者中的应用[J].医学理论与实践,2009,22(3):282-283. 被引量:20
  • 9张秀锦,李小鹰.老年心房颤动患者抗凝治疗影响因素分析[J].中华保健医学杂志,2009,11(3):183-185. 被引量:34
  • 10叶剑飞,刘晓凯.华法林在非瓣膜病高龄房颤患者抗凝治疗中的临床观察[J].现代实用医学,2009,21(9):954-955. 被引量:2

引证文献2

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部